Skip to content

Milk Supplementation and Energy Balance.

Impact of Milk Supplementation on Body Composition, Bone Density and Satiety in Women Following a Weight Loss Program.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00729170
Enrollment
41
Registered
2008-08-07
Start date
2006-10-31
Completion date
2009-02-28
Last updated
2012-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Osteoporosis

Keywords

Milk, Calcium, Weight loss, Bone density, Appetite

Brief summary

The aim of the project is to determine if milk supplementation during a caloric restriction program facilitates the lost of weight, improves the appetite control and attenuates the decrease of bone mineral content in low-calcium consumer women.

Detailed description

Calcium deficiency is related to a higher risk of obesity. Some studies showed a lost of weight by elevating the calcium consumption to reach the recommended level. Milk supplementation could be a good alternative to reach this objective, but its impact on weight loss and on appetite sensations has not been verified. Furthermore, losing weight leads to some negative consequences like a decrease of bone mineral content. Considering the benefits of milk on bone health, a higher intake of this food product during weight loss could represent a healthy strategy.

Interventions

DIETARY_SUPPLEMENTSupplementation of milk (35% more calcium)

The supplement provides 1000 mg of calcium and 250 kcal daily.

Sponsors

Dairy Farmers of Canada
CollaboratorOTHER
National Dairy Council
CollaboratorOTHER
Laval University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Low-calcium consumer (less than 800 mg daily) * BMI between 27 to 42 kg/m2 * Sedentary * Healthy

Exclusion criteria

* In menopause * Medications that alter the project's objectives * Smoker * Dietary supplement consumer * High alcohol or caffeine consumer

Design outcomes

Primary

MeasureTime frame
Body composition (body weight, fat mass, anthropometric measurements)Baseline, month 1, and month 6

Secondary

MeasureTime frame
Bone density (DXA)Baseline and month 6
Appetite sensationsBaseline, month 1, and month 6

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026